title: Design and applications of modified oligonucleotides.
abstract: Oligonucleotides have a wide range of applications in fields such as biotechnology, molecular biology, diagnosis and therapy. However, the spectrum of uses can be broadened by introducing chemical modifications into their structures. The most prolific field in the search for new oligonucleotide analogs is the antisense strategy, where chemical modifications confer appropriate characteristics such as hybridization, resistance to nucleases, cellular uptake, selectivity and, basically, good pharmacokinetic and pharmacodynamic properties. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed. Aptamers, new catalytic ribozymes and deoxyribozymes are RNA or DNA molecules individualized from a randomly synthesized library on the basis of a particular property. They are identified by repeated cycles of selection and amplification, using PCR technologies. Modified nucleotides can be introduced either during the amplification procedure or after selection.
authors.affiliation: Laboratorio de Química de Acidos Nucleicos, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, CONICET-UBA, Buenos Aires, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Gallo
authors.forename: J M
authors.initials: JM
authors.lastname: Montserrat
authors.forename: A M
authors.initials: AM
authors.lastname: Iribarren
mesh_terms: D015195:Drug Design; D015723:Gene Library; D015316:Genetic Therapy; D006801:Humans; D009841:Oligonucleotides / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use; D016337:RNA, Catalytic / Q000627:therapeutic use
chemical_list: D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic